患者体験テクノロジー市場規模、シェア、動向、2030年までの世界予測

患者体験テクノロジー市場 – 提供内容、機能[予約（オンライン予約）、登録（受付）、バーチャルケア（遠隔医療、RPM）、コミュニケーション、フィードバック]、エンドユーザー（医療提供者、支払者、製薬・バイオテクノロジー）、地域別 – 2030年までの世界予測

患者体験テクノロジー市場は、2025年の6億6,000万米ドルから2030年には11億6,000万米ドルに達し、年平均成長率（CAGR）11.8%で成長すると予測されています。この成長は、利便性とパーソナライゼーション（予約管理、デジタルチェックイン、テレトリアージ）への期待の高まり、患者アクセス／相互運用性に関する規制の強化、そしてAI、アンビエントアナリティクス、そして管理タスクを自動化し、患者のフィードバックや診療データから実用的なインサイトを引き出す会話型インターフェースの急速な導入によって牽引されています。

ベンダーは、患者体験プラットフォーム全体へのAI統合をますます進めています。例えば、2023年12月、QualtricsはEpic社との提携を発表し、患者体験データをEpic社の包括的健康記録（CHR）システムに直接統合することを目指しています。この提携では、QualtricsのAIと自然言語処理を活用し、臨床データと体験データを融合することで、医療提供者がよりパーソナライズされた、共感的なケアを提供できるようになります。この統合により、最前線のスタッフは、スケジュールに関する不満など、患者の感情をリアルタイムで察知し、それに応じた対応を行うことができるため、対応力とケアの成果が向上します。

本レポートは、患者エクスペリエンステクノロジー市場を分析しています。コンポーネント、ユースケース、収益モデル、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と将来の成長ポテンシャルを推定することを目的としています。また、主要プレーヤーの競合分析に加え、企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても解説しています。

本レポートは、既存企業だけでなく新規参入企業や中小企業にとっても、市場の動向を把握し、ひいては市場シェアの拡大に繋がる有益な情報となります。本レポートをご購入いただいた企業は、以下の戦略のいずれか、あるいは組み合わせて活用することで、市場における自社の地位を強化することができます。

Report Description

The patient experience technology market is projected to reach USD 1.16 billion by 2030 from USD 0.66 billion in 2025, at a CAGR of 11.8%. This growth is driven by increasing expectations for convenience and personalization (appointment scheduling, digital check-in, teletriage), regulatory pushes for patient access/interoperability, and rapid adoption of AI, ambient analytics, and conversational interfaces that automate administrative tasks and surface actionable insights from patient feedback and encounter data.

Vendors are increasingly integrating AI across patient experience platforms. For instance, in December 2023, Qualtrics announced a collaboration with Epic to integrate patient experience data directly into Epic’s comprehensive health record (CHR) system. The partnership leverages Qualtrics’ AI and natural language processing to fuse clinical and experiential data, enabling providers to deliver more personalized, empathetic care. The integration allows frontline staff to detect and act on patient sentiment, such as frustrations with scheduling, in real time, enhancing responsiveness and care outcomes.

Thus, such developments demonstrate that combining clinical and experiential data can drive more responsive and outcomes-focused patient care.

The cloud-based segment is expected to witness significant market share during the forecast period.

Based on the offering, the patient experience technology market is segmented into software/platform and services. The software segment is divided into on-premise, cloud-based, and hybrid. The cloud-based platform is expected to witness significant market growth during the forecast period due to its scalability, lower upfront costs, and ability to rapidly deploy updates. Healthcare providers increasingly favor cloud solutions for digital check-ins, telehealth triage, patient portals, and AI-driven personalization. Vendors such as Press Ganey, Qualtrics, and Epic are embedding cloud-native analytics, conversational AI, and ambient listening tools that improve flexibility and care access. In February 2025, Press Ganey partnered with Microsoft to develop generative AI-powered solutions that combine Press Ganey’s dataset of over 7.6 billion patient encounters with Microsoft’s AI, cloud, and ambient listening tools. This collaboration enables predictive analytics for patient safety, real-time actionable insights for providers, and secure data sharing via Azure, demonstrating that cloud-based PX platforms are driving personalization, efficiency, and improved patient experience.

Hence, such strategic collaborations underscore the growing role of cloud-based, AI-enabled patient experience platforms in delivering personalized, efficient, and data-driven care across healthcare settings.

The healthcare payers segment is expected to grow at a considerable CAGR during the forecast period.

By end user, the healthcare payers segment is expected to register the highest CAGR during the forecast period. Payers are increasingly investing in patient experience (PX) platforms to improve member engagement, streamline claims and administrative processes, and enhance overall satisfaction with health plan services. The growing emphasis on value-based care and outcomes-driven reimbursement models is prompting payers to leverage AI, analytics, and patient feedback tools to monitor service quality, predict member needs, and reduce preventable gaps in care.

Digital channels, such as member portals, teletriage, and automated communication tools, are being adopted to provide personalized, real-time support, improve adherence to preventive care, and strengthen patient loyalty. Additionally, regulatory mandates for interoperability and patient access, such as the US Cures Act and Europe’s EHDS, are accelerating payer adoption of patient experience technologies. As a result, payers are emerging as a key growth driver in the market, reflecting their strategic focus on member experience and outcomes.

Europe is expected to lead the patient experience technology market in 2025.

During the forecast period, Europe is projected to hold a substantial share of the global patient experience technology market, driven by the widespread adoption of digital health technologies, rising demand for patient-centered care, and a robust regulatory environment that prioritizes data privacy and interoperability. A major trend is the shift toward personalized healthcare, with platforms and tools designed to tailor interventions to individual patient needs, enhancing adherence, satisfaction, and clinical outcomes. Governments, healthcare authorities, and public-private partnerships are playing a pivotal role in promoting patient involvement across the healthcare ecosystem. For instance, in March 2022, the European Health Initiative, a flagship public-private collaboration in life sciences with a USD 2.46 billion budget, established a Science & Innovation Panel that actively integrates patients in every stage of research, ensuring that healthcare solutions reflect real-world patient priorities.

In addition, the European Union’s eHealth and Digital Decade initiatives are driving widespread adoption of electronic health records (EHRs), patient portals, and interoperable health systems, creating a fertile environment for patient engagement technologies. For instance, in July 2024, the European Commission released the Digital Decade 2024 study, highlighting progress toward universal access to electronic health records (EHRs) for EU citizens by 2030. The report noted that the EU27-average composite score for eHealth maturity increased from 72% to 79% in 2023, with 22 member states improving their performance.

Digital tools such as mobile health apps, telehealth platforms, AI-driven virtual assistants, and remote monitoring devices are increasingly being integrated into clinical workflows to improve communication, monitor treatment adherence, and support preventive care. Notable European vendors such as Doctrin (Sweden), Infermedica (Poland), and Cegedim (France) are actively expanding their patient engagement offerings, providing cloud-based, AI-enabled solutions that enable hospitals, clinics, and payers to enhance patient experience and operational efficiency.

These trends collectively signal that Europe will continue to be a leading region for patient engagement technology adoption, supported by ongoing government investments, regulatory incentives, and the increasing prioritization of patient empowerment in healthcare delivery.

The breakdown of primary participants is as mentioned below:

• By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation – C Level: 42%, Director Level: 31%, and Others: 27%
• By Region – North America: 35%, Europe: 30%, Asia Pacific: 25%, Middle East & Africa: 5%, Latin America: 5%

Key Players

The key players functioning in the patient experience technology market include Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), and Salesforce, Inc. (US).

Research Coverage

The report analyzes the patient experience technology market. It aims to estimate the market size and future growth potential of various market segments based on component, use case, revenue model, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms and new entrants/smaller firms to gauge the market’s pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

Analysis of key drivers: Drivers (rising demand for digital engagement platforms and personalized patient care, increasing adoption of telehealth, mobile health apps, and AI-powered analytics, government initiatives and funding for healthcare digital transformation, growing focus on improving patient satisfaction and long-term engagement, and expansion of cloud-based engagement platforms), Restraints (data privacy and cybersecurity concerns, high implementation and integration costs for healthcare providers, limited interoperability between patient engagement systems and existing EHRs), Opportunities (growth opportunities in emerging markets, adoption of AI-driven personalization and predictive analytics for patient care, strategic partnerships among technology platforms, pharma companies, and payers, and rising adoption of virtual reality and augmented reality) and Challenges (need to ensure accuracy and reliability of feedback data, rapid technological evolution) influencing the growth of the patient experience technology market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient experience technology market.
• Market Development: Comprehensive information on the lucrative emerging markets, by offerings, functions, end user, and region
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient experience technology market.
•  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient experience technology market such as Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), Salesforce, Inc. (US), Vital (US), NexHealth (US), Collectly, Inc. (US), Business Integrity Services (US), and Bamboo Health (US).

Table of Contents

1               INTRODUCTION              30

1.1           STUDY OBJECTIVES       30

1.2           MARKET DEFINITION   30

1.3           STUDY SCOPE   31

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 31

1.3.2        INCLUSIONS AND EXCLUSIONS 32

1.3.3        YEARS CONSIDERED      33

1.4           CURRENCY CONSIDERED            33

1.5           STAKEHOLDERS               34

1.6           SUMMARY OF CHANGES               34

2               RESEARCH METHODOLOGY       36

2.1           RESEARCH DATA              36

2.1.1        SECONDARY DATA          37

2.1.1.1    Key data from secondary sources       37

2.1.2        PRIMARY DATA 38

2.1.2.1    Key data from primary sources           39

2.1.2.2    Breakdown of primary sources           40

2.2           RESEARCH METHODOLOGY       41

2.3           MARKET SIZE ESTIMATION         42

2.4           MARKET BREAKDOWN AND DATA TRIANGULATION                 49

2.5           RESEARCH ASSUMPTIONS           50

2.5.1        PARAMETRIC ASSUMPTIONS     50

2.5.2        OVERALL STUDY ASSUMPTIONS              50

2.6           RESEARCH LIMITATIONS             51

2.6.1        METHODOLOGY-RELATED LIMITATIONS           51

2.6.2        SCOPE-RELATED LIMITATIONS                 51

2.7           RISK ANALYSIS  51

3               EXECUTIVE SUMMARY  52

4               PREMIUM INSIGHTS       57

4.1           PATIENT EXPERIENCE TECHNOLOGY MARKET OVERVIEW          57

4.2           NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY OFFERING AND REGION        58

4.3           PATIENT EXPERIENCE TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES            59

4.4           PATIENT EXPERIENCE TECHNOLOGY MARKET: DEVELOPED VS. EMERGING ECONOMIES             60

5               MARKET OVERVIEW       61

5.1           INTRODUCTION              61

5.2           MARKET DYNAMICS       61

5.2.1        DRIVERS               62

5.2.1.1    Rising demand for digital engagement platforms and personalized patient care    62

5.2.1.2    Increasing adoption of telehealth, mobile health apps, and

AI-powered analytics           63

5.2.1.3    Government initiatives and funding for healthcare digital transformation      64

5.2.1.4    Growing focus on improving patient satisfaction and long-term engagement           64

5.2.1.5    Expansion of cloud-based engagement platforms           65

5.2.2        RESTRAINTS      66

5.2.2.1    Data privacy and cybersecurity concerns          66

5.2.2.2    High implementation and integration costs for healthcare providers                66

5.2.2.3    Limited interoperability between patient engagement systems and existing electronic health record systems  67

5.2.3        OPPORTUNITIES              67

5.2.3.1    Growth opportunities in emerging market       67

5.2.3.2    Adoption of AI-driven personalization and predictive analytics for patient care      67

5.2.3.3    Strategic partnerships among technology providers, pharma companies, and payers         68

5.2.3.4    Rising adoption of virtual reality and augmented reality                 69

5.2.4        CHALLENGES    69

5.2.4.1    Need to ensure accuracy and reliability of feedback data                 69

5.2.4.2    Rapid technological evolution             69

5.3           INDUSTRY TRENDS         70

5.3.1        INVESTMENTS IN PATIENT ENGAGEMENT AND EXPERIENCE PLATFORMS            70

5.3.2        AI-DRIVEN PERSONALIZATION AND VIRTUAL ASSISTANTS       70

5.3.3        CLOUD-BASED PLATFORMS AND OMNICHANNEL ACCESS 70

5.3.4        TELEHEALTH AND HYBRID CARE MODELS         70

5.3.5        IMMERSIVE TECHNOLOGIES FOR EDUCATION AND ADHERENCE      71

5.4           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       71

5.5           PRICING ANALYSIS          72

5.5.1        AVERAGE SELLING PRICE TREND, BY KEY PLAYER                 72

5.5.2        AVERAGE SELLING PRICE TREND, BY REGION   73

5.6           VALUE CHAIN ANALYSIS               74

5.7           ECOSYSTEM ANALYSIS  75

5.8           INVESTMENT AND FUNDING SCENARIO               78

5.9           TECHNOLOGY ANALYSIS             78

5.9.1        KEY TECHNOLOGIES     78

5.9.1.1    Voice-of-the-Patient (VoP) platforms              78

5.9.1.2    Telehealth and virtual care platforms                79

5.9.1.3    Patient portals and personal health records     79

5.9.1.4    Remote Patient Monitoring (RPM)  79

5.9.2        COMPLEMENTARY TECHNOLOGIES       79

5.9.2.1    Interoperability/API and FHIR Infrastructure                 79

5.9.2.2    Patient identity management and authentication systems                 80

5.9.3        ADJACENT TECHNOLOGIES       80

5.9.3.1    Clinical Decision Support Systems (CDSS)    80

5.9.3.2    Population Health Management (PHM) platforms        80

5.9.3.3    Patient engagement solutions            80

5.10         PATENT ANALYSIS          81

5.10.1      PATENT PUBLICATION TRENDS               81

5.10.2      JURISDICTION ANALYSIS              82

5.10.3      MAJOR PATENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET                83

5.11         KEY CONFERENCES AND EVENTS, 2025–2027        85

5.12         CASE STUDY ANALYSIS 86

5.13         REGULATORY LANDSCAPE         88

5.13.1      REGULATORY ANALYSIS               88

5.13.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             91

5.14         PORTER’S FIVE FORCES ANALYSIS           98

5.14.1      BARGAINING POWER OF SUPPLIERS       99

5.14.2      BARGAINING POWER OF BUYERS             99

5.14.3      THREAT OF NEW ENTRANTS      99

5.14.4      THREAT OF SUBSTITUTES          99

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 100

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     100

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           100

5.15.2      KEY BUYING CRITERIA  101

5.16         END-USER ANALYSIS      102

5.16.1      UNMET NEEDS 102

5.16.2      END-USER EXPECTATIONS         103

5.17         BUSINESS MODELS         103

5.18         IMPACT OF AI/GEN AI ON PATIENT EXPERIENCE TECHNOLOGY MARKET                104

5.18.1      INTRODUCTION              104

5.18.2      MARKET POTENTIAL OF AI IN PATIENT EXPERIENCE TECHNOLOGY  104

5.18.3      AI USE CASES     105

5.18.4      CASE STUDY ON IMPLEMENTATION OF AI/GEN AI                 106

5.18.5      INTERCONNECTED AND ADJACENT ECOSYSTEMS                 107

5.18.5.1  US healthcare technology market      107

5.18.5.2  Patient engagement technology market            108

5.18.6      USER READINESS AND IMPACT ASSESSMENT     109

5.18.6.1  User readiness       109

5.18.6.1.1                Hospitals & health systems 109

5.18.6.1.2                Outpatient & ambulatory care centers              109

5.18.6.1.3                Physician and group practices            109

5.18.6.1.4                Long-term care and post-acute facilities          109

5.18.6.1.5                Others    109

5.18.6.2  Impact assessment                109

5.18.6.2.1                Implementation    109

5.18.6.2.2                Impact    110

5.19         IMPACT OF 2025 US TARIFFS ON PATIENT EXPERIENCE TECHNOLOGY MARKET                110

5.19.1      INTRODUCTION              110

5.19.2      KEY TARIFF RATES          110

5.19.3      IMPACT ON COUNTRY/REGION                111

5.19.3.1  US           111

5.19.3.2  Europe   111

5.19.3.3  Asia Pacific            111

5.19.4      IMPACT ON END-USE INDUSTRIES          112

5.19.4.1  Healthcare providers            112

5.19.4.2  Healthcare payers 112

5.19.4.3  Pharma & biotech companies             113

5.19.4.4  Others    113

6               PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING           114

6.1           INTRODUCTION              115

6.2           SOFTWARE         115

6.2.1        ON-PREMISE SOFTWARE              117

6.2.1.1    Data sovereignty and seamless workflow ability to drive market                 117

6.2.2        CLOUD-BASED SOFTWARE         118

6.2.2.1    Lower upfront costs and seamless interoperability to aid growth                 118

6.2.3        HYBRID SOFTWARE        119

6.2.3.1    Ability to ensure maximum compliance and control to boost market    119

6.3           SERVICES             121

6.3.1        MANAGED SERVICES      122

6.3.1.1    Rising demand for operational efficiency and risk mitigation to encourage growth 122

6.3.2        PROFESSIONAL SERVICES            123

6.3.2.1    Need for continuous patient engagement to contribute to growth                 123

7               PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION          125

7.1           INTRODUCTION              126

7.2           APPOINTMENT SCHEDULING   126

7.2.1        GROWING TREND TOWARD OMNICHANNEL, INTELLIGENT PATIENT EXPERIENCE SOLUTIONS TO FUEL MARKET               126

7.3           PATIENT REGISTRATION             128

7.3.1        NEED TO ENHANCE CLINICAL SAFETY AND OPERATIONAL PERFORMANCE TO AUGMENT GROWTH                 128

7.4           VIRTUAL CARE 129

7.4.1        EXPANDING REMOTE ACCESS AND CONTINUITY OF CARE TO AID GROWTH 129

7.5           PATIENT COMMUNICATION      131

7.5.1        INCREASING LAUNCHES OF COMMUNICATION PLATFORMS TO BOLSTER GROWTH       131

7.6           BILLING               133

7.6.1        INCREASING PUSH FOR TRANSPARENT AND AUTOMATED FINANCIAL WORKFLOWS TO SPUR GROWTH                 133

7.7           FEEDBACK MANAGEMENT          134

7.7.1        NEED FOR REAL-TIME INSIGHTS INTO PATIENT SATISFACTION, CARE QUALITY, AND SERVICE GAPS TO FACILITATE GROWTH   134

7.8           OTHER FUNCTIONS       136

8               PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER     137

8.1           INTRODUCTION              138

8.2           HEALTHCARE PROVIDERS           139

8.2.1        HOSPITALS & HEALTH SYSTEMS               140

8.2.1.1    Growing adoption of advanced digital and AI-driven platforms to bolster market       140

8.2.2        OUTPATIENT & AMBULATORY CARE CENTERS 142

8.2.2.1    Rising demand for preventive care, chronic disease management, and same-day procedures to promote growth  142

8.2.3        PHYSICIANS & GROUP PRACTICES           143

8.2.3.1    Increasing use of predictive analytics and remote monitoring tools to augment growth      143

8.2.4        LONG-TERM CARE & POST-ACUTE FACILITIES  145

8.2.4.1    Growing burden of aging population and chronic diseases to boost market          145

8.2.5        OTHER HEALTHCARE PROVIDERS           147

8.3           HEALTHCARE PAYERS   148

8.3.1        INCREASING ADVANCEMENTS IN ARTIFICIAL INTELLIGENCE AND VIRTUAL CARE MODELS TO FUEL MARKET                 148

8.4           PHARMA & BIOTECH COMPANIES            149

8.4.1        RISING INTEGRATION OF PATIENT EXPERIENCE TECHNOLOGY TO AID GROWTH              149

8.5           OTHER END USERS         150

9               PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION                152

9.1           INTRODUCTION              153

9.2           NORTH AMERICA             154

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 155

9.2.2        US           158

9.2.2.1    Increasing adoption of digital solutions to contribute to growth                 158

9.2.3        CANADA               161

9.2.3.1    Rising focus on healthcare delivery through digital innovation to expedite growth    161

9.3           EUROPE               164

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      164

9.3.2        UK          168

9.3.2.1    Growing focus on digital-first healthcare delivery and patient empowerment to drive market            168

9.3.3        GERMANY           171

9.3.3.1    Aging population and rising prevalence of chronic diseases to spur growth            171

9.3.4        FRANCE                174

9.3.4.1    Favorable policies and commitment to digital transformation to aid growth              174

9.3.5        ITALY    177

9.3.5.1    Expanding regulatory and reimbursement support to fuel market                 177

9.3.6        SPAIN    180

9.3.6.1    Growing adoption of telemedicine to boost market        180

9.3.7        REST OF EUROPE             183

9.4           ASIA PACIFIC     186

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 187

9.4.2        JAPAN   190

9.4.2.1    Rapidly growing elderly population to accelerate growth                 190

9.4.3        CHINA  194

9.4.3.1    Widespread integration of healthcare services into super-apps to accelerate growth 194

9.4.4        INDIA    197

9.4.4.1    Increasing burden of non-communicable diseases and use of mobile-first platforms to favor growth               197

9.4.5        SOUTH KOREA  200

9.4.5.1    Booming medical tourism to speed up growth 200

9.4.6        AUSTRALIA         203

9.4.6.1    Matured healthcare system and digital infrastructure to promote growth    203

9.4.7        REST OF ASIA PACIFIC   206

9.5           LATIN AMERICA                209

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 210

9.5.2        BRAZIL 213

9.5.2.1    Increase utilization of digital ecosystems to spur growth                 213

9.5.3        MEXICO                216

9.5.3.1    Growing consumer-driven digital marketplaces to fuel market                 216

9.5.4        REST OF LATIN AMERICA             219

9.6           MIDDLE EAST & AFRICA                222

9.6.1        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 222

9.6.2        GCC COUNTRIES              226

9.6.2.1    Rising healthcare investments to contribute to growth  226

9.6.2.2    Saudi Arabia          229

9.6.2.2.1 Digital health transformation programs to support growth                 229

9.6.2.3    UAE        232

9.6.2.3.1 Rising patient expectations and entry of innovative regional platforms to aid growth       232

9.6.2.4    Rest of GCC countries         235

9.6.3        SOUTH AFRICA 238

9.6.3.1    Growing smartphone penetration and supportive regulatory efforts to boost market         238

9.6.4        REST OF MIDDLE EAST & AFRICA             240

10            COMPETITIVE LANDSCAPE         244

10.1         OVERVIEW          244

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            244

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET           244

10.3         REVENUE ANALYSIS, 2020–2024  246

10.4         MARKET SHARE ANALYSIS, 2024                 247

10.5         COMPANY VALUATION AND FINANCIAL METRICS                 250

10.6         BRAND/SOFTWARE COMPARISON           251

10.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 252

10.7.1      STARS   252

10.7.2      EMERGING LEADERS     252

10.7.3      PERVASIVE PLAYERS      252

10.7.4      PARTICIPANTS 252

10.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         254

10.7.5.1  Company footprint               254

10.7.5.2  Region footprint   255

10.7.5.3  Offering footprint 256

10.7.5.4  Function footprint                257

10.7.5.5  End-user footprint                258

10.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        259

10.8.1      PROGRESSIVE COMPANIES         259

10.8.2      RESPONSIVE COMPANIES            259

10.8.3      DYNAMIC COMPANIES  259

10.8.4      STARTING BLOCKS         259

10.8.5      COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024        261

10.8.5.1  Detailed list of key startups/SMEs    261

10.8.5.2  Competitive benchmarking of key startups/SMEs          261

10.9         COMPETITIVE SCENARIO             262

10.9.1      SOLUTION LAUNCHES AND ENHANCEMENTS   262

10.9.2      DEALS  263

10.9.3      EXPANSIONS     264

11            COMPANY PROFILES      265

11.1         KEY PLAYERS     265

11.1.1      PRESS GANEY    265

11.1.1.1  Business overview 265

11.1.1.2  Solutions offered  265

11.1.1.3  Recent developments           266

11.1.1.3.1                Solution launches and enhancements                266

11.1.1.3.2                Deals      266

11.1.1.4  MnM view              267

11.1.1.4.1                Right to win           267

11.1.1.4.2                Strategic choices   267

11.1.1.4.3                Weaknesses and competitive threats 267

11.1.2      NATIONAL RESEARCH CORPORATION  268

11.1.2.1  Business overview 268

11.1.2.2  Solutions offered  269

11.1.2.3  Recent developments           269

11.1.2.3.1                Solution launches and enhancements                269

11.1.2.4  MnM view              270

11.1.2.4.1                Right to win           270

11.1.2.4.2                Strategic choices   270

11.1.2.4.3                Weaknesses and competitive threats 270

11.1.3      MEDALLIA INC. 271

11.1.3.1  Business overview 271

11.1.3.2  Solutions offered  271

11.1.3.3  Recent developments           272

11.1.3.3.1                Solution launches and enhancements                272

11.1.3.3.2                Deals      272

11.1.3.4  MnM view              273

11.1.3.4.1                Right to win           273

11.1.3.4.2                Strategic choices   273

11.1.3.4.3                Weaknesses and competitive threats 273

11.1.4      PHREESIA            274

11.1.4.1  Business overview 274

11.1.4.2  Solutions offered  275

11.1.4.3  Recent developments           276

11.1.4.3.1                Solution launches and enhancements                276

11.1.4.3.2                Deals      276

11.1.4.4  MnM view              277

11.1.4.4.1                Right to win           277

11.1.4.4.2                Strategic choices   277

11.1.4.4.3                Weaknesses and competitive threats 277

11.1.5      NICE      278

11.1.5.1  Business overview 278

11.1.5.2  Solutions offered  279

11.1.5.3  MnM view              280

11.1.5.3.1                Right to win           280

11.1.5.3.2                Strategic choices   280

11.1.5.3.3                Weaknesses and competitive threats 280

11.1.6      R1            281

11.1.6.1  Business overview 281

11.1.6.2  Solutions offered  281

11.1.6.3  Recent developments           282

11.1.6.3.1                Solution launches and enhancements                282

11.1.6.3.2                Deals      282

11.1.7      EPIC SYSTEMS CORPORATION  283

11.1.7.1  Business overview 283

11.1.7.2  Solutions offered  283

11.1.7.3  Recent developments           284

11.1.7.3.1                Solution launches and enhancements                284

11.1.7.3.2                Deals      284

11.1.8      IQVIA    285

11.1.8.1  Business overview 285

11.1.8.2  Solutions offered  286

11.1.8.3  Recent developments           287

11.1.8.3.1                Solution launches and enhancements                287

11.1.9      QUALTRICS        288

11.1.9.1  Business overview 288

11.1.9.2  Solutions offered  288

11.1.9.3  Recent developments           289

11.1.9.3.1                Deals      289

11.1.9.3.2                Expansions             290

11.1.9.3.3                Other developments             290

11.1.10   RELIAS LLC         291

11.1.10.1                 Business overview 291

11.1.10.2                 Solutions offered  291

11.1.10.3                 Recent developments           292

11.1.10.3.1             Deals      292

11.1.11   GETWELLNETWORK, INC.            293

11.1.11.1                 Business overview 293

11.1.11.2                 Solutions offered  293

11.1.11.3                 Recent developments           294

11.1.11.3.1             Solution launches and enhancements                294

11.1.11.3.2             Deals      294

11.1.12   CIPHERHEALTH INC.     295

11.1.12.1                 Business overview 295

11.1.12.2                 Solutions offered  295

11.1.12.3                 Recent developments           296

11.1.12.3.1             Solution launches and enhancements                296

11.1.12.3.2             Deals      296

11.1.13   KYRUUS, INC.    297

11.1.13.1                 Business overview 297

11.1.13.2                 Solutions offered  297

11.1.13.3                 Recent developments           298

11.1.13.3.1             Solution launches and enhancements                298

11.1.13.3.2             Deals      299

11.1.14   RELATIENT         300

11.1.14.1                 Business overview 300

11.1.14.2                 Solutions offered  300

11.1.14.3                 Recent developments           301

11.1.14.3.1             Solution launches and enhancements                301

11.1.15   ALIDA   302

11.1.15.1                 Business overview 302

11.1.15.2                 Solutions offered  302

11.1.15.3                 Recent developments           303

11.1.15.3.1             Other developments             303

11.1.16   TWILIO INC.       304

11.1.16.1                 Business overview 304

11.1.16.2                 Solutions offered  306

11.1.16.3                 Recent developments           306

11.1.16.3.1             Solution launches and enhancements                306

11.1.16.3.2             Deals      307

11.1.17   AVAAMO              308

11.1.17.1                 Business overview 308

11.1.17.2                 Solutions offered  308

11.1.17.3                 Recent developments           309

11.1.17.3.1             Solution launches and enhancements                309

11.1.18   CERTIFY HEALTH             310

11.1.18.1                 Business overview 310

11.1.18.2                 Solutions offered  310

11.1.18.3                 Recent developments           311

11.1.18.3.1             Other developments             311

11.1.19   LUMA HEALTH INC.        312

11.1.19.1                 Business overview 312

11.1.19.2                 Solutions offered  312

11.1.19.3                 Recent developments           313

11.1.19.3.1             Solution launches and enhancements                313

11.1.19.3.2             Deals      314

11.1.20   SOLUTIONREACH            315

11.1.20.1                 Business overview 315

11.1.20.2                 Solutions offered  315

11.1.20.3                 Recent developments           316

11.1.20.3.1             Solution launches and enhancements                316

11.1.21   SALESFORCE, INC.           317

11.1.21.1                 Business overview 317

11.1.21.2                 Solutions offered  318

11.1.21.3                 Recent developments           320

11.1.21.3.1             Solution launches and enhancements                320

11.2         OTHER PLAYERS              321

11.2.1      VITAL    321

11.2.2      NEXHEALTH      322

11.2.3      COLLECTLY, INC.             323

11.2.4      BUSINESS INTEGRITY SERVICES                324

11.2.5      BAMBOO HEALTH           325

12            APPENDIX           326

12.1         DISCUSSION GUIDE        326

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                331

12.3         CUSTOMIZATION OPTIONS        333

12.4         RELATED REPORTS         333

12.5         AUTHOR DETAILS           334

LIST OF TABLES

TABLE 1                PATIENT EXPERIENCE TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS 32

TABLE 2                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021–2024           33

TABLE 3                PATIENT EXPERIENCE TECHNOLOGY MARKET: FACTOR ANALYSIS          46

TABLE 4                PATIENT EXPERIENCE TECHNOLOGY MARKET: RISK ANALYSIS  51

TABLE 5                PATIENT EXPERIENCE TECHNOLOGY MARKET: IMPACT ANALYSIS OF

MARKET DYNAMICS       62

TABLE 6                AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE SOFTWARE,

BY KEY PLAYER, 2022–2025 (USD)              72

TABLE 7                AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY,

BY REGION, 2022–2025 (USD)      73

TABLE 8                PATIENT EXPERIENCE TECHNOLOGY MARKET:

ROLE OF COMPANIES IN ECOSYSTEM    77

TABLE 9                JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT EXPERIENCE TECHNOLOGY, 2015–2025        82

TABLE 10              PATIENT EXPERIENCE TECHNOLOGY MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2025    84

TABLE 11              PATIENT EXPERIENCE TECHNOLOGY MARKET: KEY CONFERENCES

AND EVENTS, 2025–2027                 85

TABLE 12              CASE STUDY 1: IMPROVED PATIENT-CENTERED CARE WITH DIGIVALET PATIENT EXPERIENCE PLATFORM                 86

TABLE 13              CASE STUDY 2: PAPERLESS ADMISSIONS VIA PWC + SALESFORCE

DIGITAL PATIENT PORTAL         87

TABLE 14              CASE STUDY 3: TIMELY PATIENT COMMUNICATIONS WITH TWILIO MESSAGING 87

TABLE 15              CASE STUDY 4: DIGITAL WAYFINDING & WI-FI ENHANCEMENTS

BY WORLDWIDE TECHNOLOGY                88

TABLE 16              REGULATORY SCENARIO IN NORTH AMERICA                 88

TABLE 17              REGULATORY SCENARIO IN EUROPE     89

TABLE 18              REGULATORY SCENARIO IN ASIA PACIFIC                 90

TABLE 19              REGULATORY SCENARIO IN MIDDLE EAST & AFRICA 90

TABLE 20              REGULATORY SCENARIO IN LATIN AMERICA                 91

TABLE 21              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 22              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  94

TABLE 23              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  95

TABLE 24              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  97

TABLE 25              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  97

TABLE 26              PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS           99

TABLE 27              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE

END USERS (%) 101

TABLE 28              KEY BUYING CRITERIA FOR TOP THREE END USERS   102

TABLE 29              PATIENT EXPERIENCE TECHNOLOGY MARKET: UNMET NEEDS 102

TABLE 30              PATIENT EXPERIENCE TECHNOLOGY MARKET: END-USER EXPECTATIONS         103

TABLE 31              CASE STUDY: AI-DRIVEN PATIENT EXPERIENCE ENHANCEMENT               106

TABLE 32              US ADJUSTED RECIPROCAL TARIFF RATES                 110

TABLE 33              PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            115

TABLE 34              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE,

2023–2030 (USD MILLION)            116

TABLE 35              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2030 (USD MILLION)                 116

TABLE 36              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR ON-PREMISE SOFTWARE,

BY COUNTRY, 2023–2030 (USD MILLION)               117

TABLE 37              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR CLOUD-BASED SOFTWARE,

BY COUNTRY, 2023–2030 (USD MILLION)             119

TABLE 38              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HYBRID SOFTWARE,

BY COUNTRY, 2023–2030 (USD MILLION)             120

TABLE 39              PATIENT EXPERIENCE TECHNOLOGY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            121

TABLE 40              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY COUNTRY,

2023–2030 (USD MILLION)            122

TABLE 41              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR MANAGED SERVICES,

BY COUNTRY, 2023–2030 (USD MILLION)               123

TABLE 42              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PROFESSIONAL SERVICES,

BY COUNTRY, 2023–2030 (USD MILLION)               124

TABLE 43              PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            126

TABLE 44              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR APPOINTMENT SCHEDULING,

BY COUNTRY, 2023–2030 (USD MILLION)               127

TABLE 45              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT REGISTRATION,

BY COUNTRY, 2023–2030 (USD MILLION)               129

TABLE 46              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR VIRTUAL CARE, BY COUNTRY, 2023–2030 (USD MILLION)                 130

TABLE 47              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT COMMUNICATION,

BY COUNTRY, 2023–2030 (USD MILLION)               132

TABLE 48              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR BILLING, BY COUNTRY,

2023–2030 (USD MILLION)            134

TABLE 49              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR FEEDBACK MANAGEMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               135

TABLE 50              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER FUNCTIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               136

TABLE 51              PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            138

TABLE 52              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         139

TABLE 53              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS,

BY COUNTRY, 2023–2030 (USD MILLION)               140

TABLE 54              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HOSPITALS & HEALTH SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            141

TABLE 55              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OUTPATIENT & AMBULATORY CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)     143

TABLE 56              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PHYSICIANS & GROUP PRACTICES, BY COUNTRY, 2023–2030 (USD MILLION) 144

TABLE 57              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR LONG-TERM CARE & POST-ACUTE FACILITIES, BY COUNTRY, 2023–2030 (USD MILLION)     146

TABLE 58              PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2023–2030 (USD MILLION) 147

TABLE 59              PATIENT EXPERIENCE TECHNOLOGY FOR HEALTHCARE PAYERS, BY COUNTRY, 2023–2030 (USD MILLION)                 149

TABLE 60              PATIENT EXPERIENCE TECHNOLOGY FOR PHARMA & BIOTECH COMPANIES,

BY COUNTRY, 2023–2030 (USD MILLION)               150

TABLE 61              PATIENT EXPERIENCE TECHNOLOGY FOR OTHER END USERS, BY COUNTRY,

2023–2030 (USD MILLION)            151

TABLE 62              PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION,

2023–2030 (USD MILLION)            153

TABLE 63              NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            155

TABLE 64              NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023–2030 (USD MILLION)            155

TABLE 65              NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION) 156

TABLE 66              NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         156

TABLE 67              NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            157

TABLE 68              NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            157

TABLE 69              NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                158

TABLE 70              US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            159

TABLE 71              US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         159

TABLE 72              US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE,

2023–2030 (USD MILLION)            159

TABLE 73              US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            160

TABLE 74              US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            160

TABLE 75              US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 161

TABLE 76              CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            162

TABLE 77              CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         162

TABLE 78              CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         162

TABLE 79              CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            163

TABLE 80              CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            163

TABLE 81              CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 164

TABLE 82              EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            165

TABLE 83              EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            165

TABLE 84              EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)                 166

TABLE 85              EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)                 166

TABLE 86              EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            167

TABLE 87              EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            167

TABLE 88              EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 168

TABLE 89              UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            169

TABLE 90              UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)                 169

TABLE 91              UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE,

2023–2030 (USD MILLION)            169

TABLE 92              UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            170

TABLE 93              UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            170

TABLE 94              UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 171

TABLE 95              GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            172

TABLE 96              GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         172

TABLE 97              GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         172

TABLE 98              GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            173

TABLE 99              GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            173

TABLE 100            GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                174

TABLE 101            FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            175

TABLE 102            FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         175

TABLE 103            FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         175

TABLE 104            FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            176

TABLE 105            FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            176

TABLE 106            FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 177

TABLE 107            ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            178

TABLE 108            ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)                 178

TABLE 109            ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)                 178

TABLE 110            ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            179

TABLE 111            ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            179

TABLE 112            ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 180

TABLE 113            SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            181

TABLE 114            SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)                 181

TABLE 115            SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)                 181

TABLE 116            SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            182

TABLE 117            SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            182

TABLE 118            SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 183

TABLE 119            REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023–2030 (USD MILLION)            184

TABLE 120            REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION) 184

TABLE 121            REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         184

TABLE 122            REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            185

TABLE 123            REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            185

TABLE 124            REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                186

TABLE 125            ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            188

TABLE 126            ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            188

TABLE 127            ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         188

TABLE 128            ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         189

TABLE 129            ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            189

TABLE 130            ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            190

TABLE 131            ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                190

TABLE 132            JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            191

TABLE 133            JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)                 191

TABLE 134            JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)                 192

TABLE 135            JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            192

TABLE 136            JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            193

TABLE 137            JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 193

TABLE 138            CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            194

TABLE 139            CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)                 195

TABLE 140            CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)                 195

TABLE 141            CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            196

TABLE 142            CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            196

TABLE 143            CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 197

TABLE 144            INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            198

TABLE 145            INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)                 198

TABLE 146            INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)                 198

TABLE 147            INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            199

TABLE 148            INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            199

TABLE 149            INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 200

TABLE 150            SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023–2030 (USD MILLION)            201

TABLE 151            SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         201

TABLE 152            SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         201

TABLE 153            SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            202

TABLE 154            SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            202

TABLE 155            SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                203

TABLE 156            AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            204

TABLE 157            AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         204

TABLE 158            AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         204

TABLE 159            AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            205

TABLE 160            AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            205

TABLE 161            AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                206

TABLE 162            REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY OFFERING, 2023–2030 (USD MILLION)               207

TABLE 163            REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION) 207

TABLE 164            REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION) 207

TABLE 165            REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             208

TABLE 166            REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY END USER, 2023–2030 (USD MILLION)               208

TABLE 167            REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                209

TABLE 168            LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            210

TABLE 169            LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023–2030 (USD MILLION)            210

TABLE 170            LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         211

TABLE 171            LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         211

TABLE 172            LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            212

TABLE 173            LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            212

TABLE 174            LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                213

TABLE 175            BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            214

TABLE 176            BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         214

TABLE 177            BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         214

TABLE 178            BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            215

TABLE 179            BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            215

TABLE 180            BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 216

TABLE 181            MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            217

TABLE 182            MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)                 217

TABLE 183            MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)                 217

TABLE 184            MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            218

TABLE 185            MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            218

TABLE 186            MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 219

TABLE 187            REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY OFFERING, 2023–2030 (USD MILLION)               220

TABLE 188            REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)            220

TABLE 189            REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)            220

TABLE 190            REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             221

TABLE 191            REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY END USER, 2023–2030 (USD MILLION)               221

TABLE 192            REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET

FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            222

TABLE 193            MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               223

TABLE 194            MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY OFFERING, 2023–2030 (USD MILLION)               223

TABLE 195            MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET

FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)      224

TABLE 196            MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET

FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)          224

TABLE 197            MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             225

TABLE 198            MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY END USER, 2023–2030 (USD MILLION)               225

TABLE 199            MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                226

TABLE 200            GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023–2030 (USD MILLION)            227

TABLE 201            GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION) 227

TABLE 202            GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         227

TABLE 203            GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            228

TABLE 204            GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            228

TABLE 205            GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                229

TABLE 206            SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023–2030 (USD MILLION)            230

TABLE 207            SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         230

TABLE 208            SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         230

TABLE 209            SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            231

TABLE 210            SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            231

TABLE 211            SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                232

TABLE 212            UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2023–2030 (USD MILLION)            233

TABLE 213            UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         233

TABLE 214            UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         233

TABLE 215            UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            234

TABLE 216            UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            234

TABLE 217            UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 235

TABLE 218            REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY OFFERING, 2023–2030 (USD MILLION)               235

TABLE 219            REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET

FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)      236

TABLE 220            REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET

FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)          236

TABLE 221            REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             236

TABLE 222            REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY END USER, 2023–2030 (USD MILLION)               237

TABLE 223            REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)               237

TABLE 224            SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023–2030 (USD MILLION)            238

TABLE 225            SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,

BY TYPE, 2023–2030 (USD MILLION)         239

TABLE 226            SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         239

TABLE 227            SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            239

TABLE 228            SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            240

TABLE 229            SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                240

TABLE 230            REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY OFFERING, 2023–2030 (USD MILLION)               241

TABLE 231            REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023–2030 (USD MILLION)            241

TABLE 232            REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023–2030 (USD MILLION)            242

TABLE 233            REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             242

TABLE 234            REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,

BY END USER, 2023–2030 (USD MILLION)               243

TABLE 235            REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)               243

TABLE 236            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, JANUARY 2022–SEPTEMBER 2025                244

TABLE 237            PATIENT EXPERIENCE TECHNOLOGY MARKET: DEGREE OF COMPETITION         248

TABLE 238            PATIENT EXPERIENCE TECHNOLOGY MARKET: REGION FOOTPRINT     255

TABLE 239            PATIENT EXPERIENCE TECHNOLOGY MARKET: OFFERING FOOTPRINT 256

TABLE 240            PATIENT EXPERIENCE TECHNOLOGY MARKET: FUNCTION FOOTPRINT                257

TABLE 241            PATIENT EXPERIENCE TECHNOLOGY MARKET: END-USER FOOTPRINT 258

TABLE 242            PATIENT EXPERIENCE TECHNOLOGY MARKET: DETAILED LIST OF

KEY STARTUPS/SMES    261

TABLE 243            PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPETITIVE

BENCHMARKING OF KEY STARTUPS/SMES          261

TABLE 244            PATIENT EXPERIENCE TECHNOLOGY MARKET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025              262

TABLE 245            PATIENT EXPERIENCE TECHNOLOGY MARKET: DEALS,

JANUARY 2022–SEPTEMBER 2025                263

TABLE 246            PATIENT EXPERIENCE TECHNOLOGY MARKET: EXPANSIONS,

JANUARY 2022–SEPTEMBER 2025                264

TABLE 247            PRESS GANEY: COMPANY OVERVIEW     265

TABLE 248            PRESS GANEY: SOLUTIONS OFFERED     265

TABLE 249            PRESS GANEY: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                266

TABLE 250            PRESS GANEY: DEALS, JANUARY 2022–SEPTEMBER 2025              266

TABLE 251            NATIONAL RESEARCH CORPORATION: COMPANY OVERVIEW   268

TABLE 252            NATIONAL RESEARCH CORPORATION: SOLUTIONS OFFERED   269

TABLE 253            NATIONAL RESEARCH CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025              269

TABLE 254            MEDALLIA INC.: COMPANY OVERVIEW 271

TABLE 255            MEDALLIA INC.: SOLUTIONS OFFERED 271

TABLE 256            MEDALLIA INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                272

TABLE 257            MEDALLIA INC.: DEALS, JANUARY 2022–SEPTEMBER 2025              272

TABLE 258            PHREESIA: COMPANY OVERVIEW             274

TABLE 259            PHREESIA: SOLUTIONS OFFERED             275

TABLE 260            PHREESIA: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                276

TABLE 261            PHREESIA: DEALS, JANUARY 2022–SEPTEMBER 2025        276

TABLE 262            NICE: COMPANY OVERVIEW       278

TABLE 263            NICE: SOLUTIONS OFFERED       279

TABLE 264            R1: COMPANY OVERVIEW            281

TABLE 265            R1: SOLUTIONS OFFERED            281

TABLE 266            R1: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                282

TABLE 267            R1: DEALS, JANUARY 2022–SEPTEMBER 2025                 282

TABLE 268            EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW          283

TABLE 269            EPIC SYSTEMS CORPORATION: SOLUTIONS OFFERED             283

TABLE 270            EPIC SYSTEMS CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025        284

TABLE 271            EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025                284

TABLE 272            IQVIA: COMPANY OVERVIEW     285

TABLE 273            IQVIA: SOLUTIONS OFFERED     286

TABLE 274            IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                287

TABLE 275            QUALTRICS: COMPANY OVERVIEW         288

TABLE 276            QUALTRICS: SOLUTIONS OFFERED         288

TABLE 277            QUALTRICS: DEALS, JANUARY 2022–SEPTEMBER 2025        289

TABLE 278            QUALTRICS: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025              290

TABLE 279            QUALTRICS: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025                290

TABLE 280            RELIAS LLC: COMPANY OVERVIEW          291

TABLE 281            RELIAS LLC: SOLUTIONS OFFERED         291

TABLE 282            RELIAS LLC: DEALS, JANUARY 2022–SEPTEMBER 2025        292

TABLE 283            GETWELLNETWORK, INC.: COMPANY OVERVIEW          293

TABLE 284            GETWELLNETWORK, INC.: SOLUTIONS OFFERED             293

TABLE 285            GETWELLNETWORK, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                294

TABLE 286            GETWELLNETWORK, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025   294

TABLE 287            CIPHERHEALTH INC.: COMPANY OVERVIEW                 295

TABLE 288            CIPHERHEALTH INC.: SOLUTIONS OFFERED                 295

TABLE 289            CIPHERHEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                296

TABLE 290            CIPHERHEALTH INC.: DEALS, JANUARY 2022–SEPTEMBER 2025              296

TABLE 291            KYRUUS, INC.: COMPANY OVERVIEW     297

TABLE 292            KYRUUS, INC.: SOLUTIONS OFFERED     297

TABLE 293            KYRUUS, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025              298

TABLE 294            KYRUUS, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025              299

TABLE 295            RELATIENT: COMPANY OVERVIEW         300

TABLE 296            RELATIENT: SOLUTIONS OFFERED         300

TABLE 297            RELATIENT: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                301

TABLE 298            ALIDA: COMPANY OVERVIEW    302

TABLE 299            ALIDA: SOLUTIONS OFFERED    302

TABLE 300            ALIDA: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025   303

TABLE 301            TWILIO INC.: COMPANY OVERVIEW        304

TABLE 302            TWILIO INC.: SOLUTIONS OFFERED       306

TABLE 303            TWILIO INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                306

TABLE 304            TWILIO INC.: DEALS, JANUARY 2022–SEPTEMBER 2025              307

TABLE 305            AVAAMO: COMPANY OVERVIEW               308

TABLE 306            AVAAMO: SOLUTIONS OFFERED              308

TABLE 307            AVAAMO: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                309

TABLE 308            CERTIFY HEALTH: COMPANY OVERVIEW                 310

TABLE 309            CERTIFY HEALTH: SOLUTIONS OFFERED                 310

TABLE 310            CERTIFY HEALTH: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025                311

TABLE 311            LUMA HEALTH INC.: COMPANY OVERVIEW                 312

TABLE 312            LUMA HEALTH INC.: SOLUTIONS OFFERED                 312

TABLE 313            LUMA HEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                313

TABLE 314            LUMA HEALTH INC.: DEALS, JANUARY 2022–SEPTEMBER 2025              314

TABLE 315            SOLUTIONREACH: COMPANY OVERVIEW                 315

TABLE 316            SOLUTIONREACH: SOLUTIONS OFFERED                 315

TABLE 317            SOLUTIONREACH: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                316

TABLE 318            SALESFORCE, INC.: COMPANY OVERVIEW                 317

TABLE 319            SALESFORCE, INC.: SOLUTIONS OFFERED                 318

TABLE 320            SALESFORCE, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                320

TABLE 321            VITAL: COMPANY OVERVIEW    321

TABLE 322            NEXHEALTH: COMPANY OVERVIEW       322

TABLE 323            COLLECTLY, INC.: COMPANY OVERVIEW                 323

TABLE 324            BUSINESS INTEGRITY SERVICES: COMPANY OVERVIEW          324

TABLE 325            BAMBOO HEALTH: COMPANY OVERVIEW                 325

LIST OF FIGURES

FIGURE 1              PATIENT EXPERIENCE TECHNOLOGY MARKET SEGMENTATION

AND REGIONAL SCOPE 31

FIGURE 2              RESEARCH DESIGN         36

FIGURE 3              PRIMARY SOURCES         38

FIGURE 4              INSIGHTS FROM INDUSTRY EXPERTS     40

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     40

FIGURE 6              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           41

FIGURE 7              SUPPLY-SIDE MARKET ESTIMATION      43

FIGURE 8              PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ESTIMATION APPROACH         43

FIGURE 9              BOTTOM-UP APPROACH              45

FIGURE 10           CAGR PROJECTIONS FROM MARKET DYNAMICS, 2025–2030              47

FIGURE 11            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 48

FIGURE 12            TOP-DOWN APPROACH                48

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 49

FIGURE 14            PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,

2025 VS. 2030 (USD MILLION)      53

FIGURE 15            PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,

2025 VS. 2030 (USD MILLION)      54

FIGURE 16            PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      55

FIGURE 17            PATIENT EXPERIENCE TECHNOLOGY MARKET: GEOGRAPHICAL SNAPSHOT       56

FIGURE 18            INCREASING FOCUS ON PATIENT-CENTERED CARE TO DRIVE MARKET             57

FIGURE 19            SOFTWARE SEGMENT AND US LED NORTH AMERICAN MARKET IN 2025        58

FIGURE 20            INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       59

FIGURE 21            EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD          60

FIGURE 22            PATIENT EXPERIENCE TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 61

FIGURE 23            PATIENT EXPERIENCE TECHNOLOGY MARKET: TRENDS/DISRUPTIONS

IMPACTING CUSTOMERS’ BUSINESSES 71

FIGURE 24            AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY,

BY REGION, 2022–2025 (USD)      73

FIGURE 25            PATIENT EXPERIENCE TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS               74

FIGURE 26            PATIENT EXPERIENCE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS  76

FIGURE 27            RECENT FUNDING OF PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET    78

FIGURE 28            GLOBAL PATENT PUBLICATION TRENDS IN PATIENT EXPERIENCE

TECHNOLOGY, 2015–2025              81

FIGURE 29            JURISDICTION ANALYSIS OF PATIENT EXPERIENCE TECHNOLOGY

PATENTS, JANUARY 2015–AUGUST 2025 82

FIGURE 30            PATIENT EXPERIENCE TECHNOLOGY MARKET: PATENT ANALYSIS,

JANUARY 2015–AUGUST 2025       83

FIGURE 31            PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS           98

FIGURE 32            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS            100

FIGURE 33            KEY BUYING CRITERIA FOR TOP THREE END USERS   101

FIGURE 34            MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING PATIENT EXPERIENCE TECHNOLOGY ACROSS INDUSTRIES       105

FIGURE 35            IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS   107

FIGURE 36            NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT        154

FIGURE 37            ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT        187

FIGURE 38            PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ANALYSIS OF

KEY PLAYERS, 2020–2024 (USD MILLION)               247

FIGURE 39            MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2024      248

FIGURE 40            EV/EBITDA OF KEY VENDORS   250

FIGURE 41            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS  250

FIGURE 42            PATIENT EXPERIENCE TECHNOLOGY MARKET: BRAND/SOFTWARE COMPARISON           251

FIGURE 43            PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024  253

FIGURE 44            PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY FOOTPRINT 254

FIGURE 45            PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 260

FIGURE 46            NATIONAL RESEARCH CORPORATION: COMPANY SNAPSHOT (2024)      268

FIGURE 47            PHREESIA: COMPANY SNAPSHOT (2024)                 275

FIGURE 48            NICE: COMPANY SNAPSHOT (2024)          279

FIGURE 49            IQVIA: COMPANY SNAPSHOT (2024)        286

FIGURE 50            TWILIO INC.: COMPANY SNAPSHOT (2024)                 305

FIGURE 51            SALESFORCE, INC.: COMPANY SNAPSHOT (2024)                 318

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧